PCVX vs BIIB: Which Stock is Better?
Side-by-side comparison of Vaxcyte Inc and Biogen Inc in 2026
PCVX
Vaxcyte Inc
$60.45
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | PCVX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $9.11B | $25.83B | BIIB |
| P/E Ratio | N/A | 20.05 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze PCVX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCVX or BIIB a better investment?
Comparing PCVX and BIIB: Vaxcyte Inc has a market cap of $9.11B while Biogen Inc has $25.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCVX and BIIB?
PCVX (Vaxcyte Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCVX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PCVX or BIIB?
PCVX has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: PCVX or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for PCVX.
Which is the larger company: PCVX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.83B compared to $9.11B for PCVX.
Should I buy PCVX or BIIB in 2026?
Both PCVX and BIIB have investment merit. PCVX trades at $60.45 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCVX and BIIB stock?
Key differences: Market Cap ($9.11B vs $25.83B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).